LEADER 01109oam  2200349zu 450 
001 9910144702303321
005 20210807003037.0
010   $a3-527-62086-9
035   $a(CKB)1000000000687481
035   $a(SSID)ssj0000388113
035   $a(PQKBManifestationID)12154469
035   $a(PQKBTitleCode)TC0000388113
035   $a(PQKBWorkID)10430969
035   $a(PQKB)11605829
035   $a(EXLCZ)991000000000687481
100   $a20160829d1999      uy              
101 0 $aeng
181   $ctxt
182   $cc
183   $acr
200 10$aBiotechnology, Recombinant Proteins, Monoclonal Antibodies, and Therapeutic Genes. Vol. 5
210 31$a[Place of publication not identified]$cWiley VCH Imprint$d1999
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a3-527-28315-3 
700   $aMountain$b A$0991016
702   $aSchomburg$b Dietmar
702   $aNey$b U. M
801  0$bPQKB
906   $aBOOK
912   $a9910144702303321
996   $aBiotechnology, Recombinant Proteins, Monoclonal Antibodies, and Therapeutic Genes. Vol. 5$92267840
997   $aUNINA

LEADER 01121cam0-22003971i-450 
001 990007876940403321
005 20230713105838.0
010   $a88-14-07872-6
035   $a000787694
035   $aFED01000787694
035   $a(Aleph)000787694FED01
100   $a20040429d1999----km-y0itay50------ba
101 0 $aita
102   $aIT
105   $ay-------001yy
200 1 $a<<La >>securitization$fPaolo Bontempi, Gianni Scagliarini
210   $aMilano$cGiuffrè$d1999
215   $aXII, 275 p.$d21 cm
225 1 $aTeoria e pratica del diritto$hSez. 2.$iDiritto commerciale$v23
327 0 $aAppendice legislativa
610 0 $aCredito al consumo
676   $a346.073$v20$zit
676   $a346.08
700  1$aBontempi,$bPaolo$f<1963->$0149521
701  1$aScagliarini,$bGianni$0241167
801  0$aIT$bUNINA$gRICA$2UNIMARC
901   $aBK
912   $a990007876940403321
952   $aXX 23 (23)$b40098*$fFGBC
952   $a21-CB-652$b11201$fDDCP
952   $aC2-P45-05-RA$b8297$fECA
959   $aECA
959   $aFGBC
959   $aDDCP
996   $aSecuritization$9672597
997   $aUNINA